Amel Sadraoui

508 total citations
35 papers, 419 citations indexed

About

Amel Sadraoui is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Amel Sadraoui has authored 35 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 21 papers in Hepatology and 9 papers in Infectious Diseases. Recurrent topics in Amel Sadraoui's work include Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (14 papers). Amel Sadraoui is often cited by papers focused on Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (21 papers) and Liver Disease Diagnosis and Treatment (14 papers). Amel Sadraoui collaborates with scholars based in Tunisia, France and United States. Amel Sadraoui's co-authors include Henda Triki, Olfa Bahri, Ahlem Ben Yahia, N. Maàmouri, Walid Hammami, Hinda Triki, Koussay Dellagi, Anissa Chouikha, Jalel Boukadida and Naïla Hannachi and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and BMC Genomics.

In The Last Decade

Amel Sadraoui

33 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amel Sadraoui Tunisia 13 298 245 112 93 21 35 419
Mouna Lazrek France 9 96 0.3× 40 0.2× 126 1.1× 103 1.1× 27 1.3× 35 250
Niro Ujiie Japan 8 506 1.7× 499 2.0× 99 0.9× 39 0.4× 7 0.3× 13 663
Alfredo P. Martínez Argentina 13 231 0.8× 137 0.6× 178 1.6× 17 0.2× 42 2.0× 31 353
Yoshitaka Etoh Japan 11 308 1.0× 368 1.5× 55 0.5× 17 0.2× 13 0.6× 19 422
Scott G. Baginski United States 9 84 0.3× 82 0.3× 49 0.4× 126 1.4× 31 1.5× 15 516
Seizaburo Kashiwagi Japan 11 267 0.9× 262 1.1× 31 0.3× 17 0.2× 8 0.4× 26 397
Chompoonut Auphimai Thailand 14 131 0.4× 83 0.3× 312 2.8× 37 0.4× 40 1.9× 26 438
Dianne Irish United Kingdom 11 179 0.6× 150 0.6× 73 0.7× 9 0.1× 9 0.4× 19 271
Masakazu Umemoto Japan 11 62 0.2× 34 0.1× 93 0.8× 50 0.5× 19 0.9× 28 291
Rhonda McCaw Australia 9 322 1.1× 332 1.4× 74 0.7× 10 0.1× 19 0.9× 12 407

Countries citing papers authored by Amel Sadraoui

Since Specialization
Citations

This map shows the geographic impact of Amel Sadraoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amel Sadraoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amel Sadraoui more than expected).

Fields of papers citing papers by Amel Sadraoui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amel Sadraoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amel Sadraoui. The network helps show where Amel Sadraoui may publish in the future.

Co-authorship network of co-authors of Amel Sadraoui

This figure shows the co-authorship network connecting the top 25 collaborators of Amel Sadraoui. A scholar is included among the top collaborators of Amel Sadraoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amel Sadraoui. Amel Sadraoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lorusso, Alessio, Najla Mekki, Iolanda Mangone, et al.. (2025). SARS-CoV-2 excretion and genetic evolution in nasopharyngeal and stool samples from primary immunodeficiency and immunocompetent pediatric patients. Virology Journal. 22(1). 9–9.
3.
Boubaker, S, Anissa Chouikha, Daniel Bourquain, et al.. (2021). Identification of two novel hepatitis C virus subtype 2 from Tunisia (2v and 2w). PLoS ONE. 16(3). e0248249–e0248249. 4 indexed citations
4.
Bettaieb, Jihène, Anissa Chouikha, Adel Gharbi, et al.. (2019). Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study. Archives of Virology. 164(9). 2243–2253. 10 indexed citations
5.
Chouikha, Anissa, Walid Hammami, Amel Sadraoui, et al.. (2019). Hepatitis viruses take advantage of traditional practices to increase the burden of hepatocellular carcinoma in Tunisia. Archives of Virology. 165(1). 33–42. 6 indexed citations
6.
Ghedira, Kaïs, et al.. (2019). Tracing the epidemic history of hepatitis C virus genotype 1b in Tunisia and in the world, using a Bayesian coalescent approach. Infection Genetics and Evolution. 75. 103944–103944. 2 indexed citations
7.
Sadraoui, Amel, et al.. (2016). Genotype Distribution and Prevalence of Human Pegivirus among High-Risk Populations in Tunisia. Intervirology. 59(3). 170–178. 5 indexed citations
8.
Ghedira, Kaïs, Anissa Chouikha, Ahlem Ben Yahia, et al.. (2016). Phylogenetic Analysis and Epidemic History of Hepatitis C Virus Genotype 2 in Tunisia, North Africa. PLoS ONE. 11(4). e0153761–e0153761. 13 indexed citations
9.
Yahia, Ahlem Ben, et al.. (2013). Subtyping genotype 2 hepatitis C viruses from Tunisia: identification of two putative new subtypes. Virus Genes. 48(2). 209–217. 7 indexed citations
10.
Bahri, Olfa, Nissaf Ben Alaya, Ahlem Ben Yahia, et al.. (2012). Frequency and clinical significance of core promoter and precore region mutations in Tunisian patients infected chronically with hepatitis B. Journal of Medical Virology. 84(11). 1719–1726. 15 indexed citations
11.
Bahri, Olfa, et al.. (2010). Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa. Virology Journal. 7(1). 229–229. 13 indexed citations
12.
Bahri, Olfa, et al.. (2008). Genetic variability of genotype 1 hepatitis C virus isolates from Tunisian haemophiliacs.. PubMed. 31(4). 473–80. 12 indexed citations
13.
Hannachi, Naïla, Olfa Bahri, Salma Mhalla, et al.. (2008). Hépatite virale B chez les femmes enceintes tunisiennes : facteurs de risque et intérêt de l’étude de la réplication virale en cas d’antigène HBe négatif. Pathologie Biologie. 57(3). e43–e47. 24 indexed citations
14.
Bahri, Olfa, et al.. (2008). Marqueurs sérologiques, ARN viral et génotype du virus de l’hépatite delta chez des patients tunisiens antigène HBs positifs. Pathologie Biologie. 57(7-8). 518–523. 14 indexed citations
15.
Triki, Henda, et al.. (2006). Molecular characterisation of a coxsackievirus A24 that caused an outbreak of acute haemorrhagic conjunctivitis, Tunisia 2003. Clinical Microbiology and Infection. 13(2). 176–182. 19 indexed citations
16.
Bahri, Olfa, et al.. (2006). Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. Journal of Medical Virology. 78(3). 353–357. 43 indexed citations
17.
Bahri, Olfa, et al.. (2006). Identification des sérotypes d'adénovirus impliqués dans les conjonctivites hémorragiques en Tunisie. Pathologie Biologie. 54(10). 561–565. 4 indexed citations
18.
Triki, Hinda, et al.. (2005). Infections par des virus transmissibles par le sang chez des hémophiles en Tunisie. Transfusion Clinique et Biologique. 12(4). 301–305. 20 indexed citations
19.
Triki, Henda, et al.. (2003). Genotypes of hepatitis C virus circulating in Tunisia. Epidemiology and Infection. 130(3). 501–505. 44 indexed citations
20.
Sadraoui, Amel, et al.. (1997). Association crème Emla® et protoxyde d'azote pour l'abord veineux chez l'enfant. Annales Françaises d Anesthésie et de Réanimation. 16(5). 488–491. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026